TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | 0 | -4 | 18 | 124 | 0 | 35 |
| P | %wins | 100 | 100 | 0 | 100 | 100 | 80 | ||||
| S | %ret | 1 | 1 | 2 | -3 | 1 | -6 | 5 | 124 | 0 | 24 |
| S | %wins | 50 | 50 | 100 | 50 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/24/18 16:18 | 10/22/18 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Hatteras Venture Advisors Iii, LLC | NC | T | P.d | 1,500 | 5.00 | 0 | 300 | 14 | 2,458 | I | |||||||||||||||
1/19/17 17:53 | 1/17/17 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hatteras Venture Advisors Iii, LLC | NC | TH | May be p | S.m | -218 | 8.63 | 2 | -25 | -1 | 1,758 | I | 32 | -60 | -42 | -5 | -15 | -6 | -6 | 1 | -7 | -9 | ||||
6/7/16 16:38 | 6/7/16 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hatteras Venture Advisors Iii, LLC | NC | T | S.d | 0 | 7.00 | 7 | 0 | 0 | 1,783 | I | 1 | 0 | -4 | 18 | 124 | ||||||||||
6/7/16 16:38 | 6/7/16 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hatteras Venture Advisors Iii, LLC | NC | T | P.d | 750 | 7.00 | 7 | 107 | 6 | 1,783 | I | 1 | 0 | -4 | 18 | 124 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |